Health Care • Biotechnology: Pharmaceutical Preparations
$151.58 ▲ +4.11
(+2.79%)
MKT CAP: $2.18B • VOL: 343.0K
52W L $72 52W H $161
ROARABLE / RQD
D • 46/100
PIOTROSKI
2 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$127
MEDIAN
$170
MEAN
$173
HIGH
$206
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE PVLA TAPE
PVLA // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $183.41 | $174.32 | 2025-02-14 | $137.94 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $190.99 | $178.86 | 2025-02-06 | $142.49 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $172.80 | $166.74 | 2025-01-29 | $145.52 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $154.61 | — | 2025-01-17 | $148.55 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $133.39 | $144.00 | 2025-01-09 | $134.91 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $180.38 | $157.64 | 2024-12-18 | $131.87 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $147.03 | $153.10 | 2024-12-04 | $140.97 | -4.3% | 48% | C |